A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design.
Vaccine
; 27(9): 1400-9, 2009 Feb 25.
Article
in En
| MEDLINE
| ID: mdl-19150476
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bacterial Proteins
/
Vaccines
/
Vaccines, Synthetic
/
Lipoproteins
Language:
En
Journal:
Vaccine
Year:
2009
Type:
Article